Editorial
Time for new long-term trials of postmenopausal hormone therapies!
- PMID: 15006246
Item in Clipboard
Editorial
Time for new long-term trials of postmenopausal hormone therapies!
Climacteric.
2003 Dec.
No abstract available
Comment on
-
Ethical issues in the use of complementary medicines.Climacteric. 2003 Dec;6(4):268-72. Climacteric. 2003. PMID: 15006247 No abstract available.
-
Review of alternative therapies for treatment of menopausal symptoms.Climacteric. 2003 Dec;6(4):278-84. Climacteric. 2003. PMID: 15006249 Review.
-
Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.Climacteric. 2003 Dec;6(4):302-10; discussion 310-3. Climacteric. 2003. PMID: 15006251
-
Progestins initiate adverse events of menopausal estrogen therapy.Climacteric. 2003 Dec;6(4):293-301. Climacteric. 2003. PMID: 15011717
Similar articles
-
Postmenopausal hormone replacement therapy: does the progestin make a difference?J S C Med Assoc. 2002 Feb;98(1):12-9. J S C Med Assoc. 2002. PMID: 11859600 Review. No abstract available.
-
Postmenopausal hormone therapy and cardiovascular risk.J Fam Pract. 1996 Nov;43(5):437-8. J Fam Pract. 1996. PMID: 8917138 No abstract available.
-
Hormone replacement therapy: estrogen after menopause.Pharmacotherapy. 1996 May-Jun;16(3):366-75. Pharmacotherapy. 1996. PMID: 8726594 No abstract available.
-
Landmark hormone replacement therapy study stopped after finding more harms than benefits.Rep Med Guidel Outcomes Res. 2002 Aug 9;13(15):5-7. Rep Med Guidel Outcomes Res. 2002. PMID: 12553323 No abstract available.
-
The controversy over estrogen replacement therapy: an update on clinical trials.Curr Womens Health Rep. 2002 Apr;2(2):89-94. Curr Womens Health Rep. 2002. PMID: 12116607 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical